Live Breaking News & Updates on எமிலி கேன்டர் ஃபிட்ஸ்‌ஜெரல்ட்

Stay updated with breaking news from எமிலி கேன்டர் ஃபிட்ஸ்‌ஜெரல்ட். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Intercept Pharmaceuticals Inc (ICPT) Q1 2021 Earnings Call Transcript


Operator
Welcome to the Q1 2021 Intercept Pharmaceuticals Earnings Call. My name is Anette, and I ll be your operator for today s call. [Operator Instructions]
I will now turn the call over to Lisa DeFrancesco. Lisa, you may begin.
Lisa DeFrancesco
Senior Vice President of Investor Relations and Corporate Affairs
Thank you. Good morning, and thank you for joining us on today s call. This morning, we issued a press release announcing our first quarter 2021 results and financial position, which is available on our website at www.interceptpharma.com. Before we begin our discussion, I d like to note that during our call, we will be making forward-looking statements, including statements regarding our approved product and clinical development program; certain regulatory matters; and our strategy, prospects, financial guidance and future commercial and financial performance. Listeners are cautioned not to place undue reliance on these forward-looking statements, w ....

United States , Gail Cawkwell , Jerome Durso , Raymond James , Chris Weyer , Linda Richardson , Steve Seedhouse , Jay Olson Oppenheimer , Lisa Defrancesco , Michael Yee , Jerry Durso , Brian Abrahams , Jay Olson , Rocco Venezia , David Cithu , Mark Pruzanski , Ryan Deschner , Piper Sandler , Jesse Piper Sandler , Navin Jacob , Ryan Deschner Raymond James , Thomas Smith , Emily Cantor Fitzgerald , Cantor Fitzgerald , Intercept Pharmaceuticals Inc , Intercept Pharmaceuticals Earnings Call ,

Aurinia Pharmaceuticals Inc (AUPH) Q4 2020 Earnings Call Transcript


Operator
Greetings, and welcome to the Aurinia Year-end 2020 Financial Results Conference Call. [Operator Instructions] As a reminder, this conference is recorded. It s now my pleasure to turn the call over to Glenn Schulman, Senior Vice President, Investor Relations. Please go ahead, sir.
Glenn Schulman
Senior Vice President, Corporate Communications and Investor Relations
Thank you, Kevin, and good afternoon, everyone. I m pleased to welcome you to today s call discussing Aurinia s fourth quarter and year-end financial results. Joining me on the call this afternoon are Peter Greenleaf, President and CEO of Aurinia; Neil Solomons, our Chief Medical Officer; Max Colao, Chief Commercial Officer; and Joe Miller, our Chief Financial Officer. This afternoon, just after 4:00 p.m., we issued a press release announcing our financial results and recent operational highlights, which is accessible from our website at www.auriniapharma.com and has been filed on a Form 8-K ....

United States , Switzerland General , Peter Greenleaf , Glenn Schulman , Maury Raycroft , Neil Solomons , Max Colao , Alethia Young , Justin Kim , Emily Cantor Fitzgerald , Joe Miller , Otsuka Pharmaceuticals , Aurinia Pharmaceuticals Inc , Aurinia Alliance , Maurice Thomas Raycroft Jefferies , Exchange Commission , Cowen Company , Justin Alexander Kim Oppenheimer Co , Cantor Fitzgerald , Corporate Communications , Devices Agency , Company Analyst , Aurinia Year End , Results Conference , Senior Vice President , Vice President ,